SynCore Biotechnology Co

SynCore Biotechnology Co News

News

0

Ticker

4192.TWO

ISIN

TW0004192000

Revenue Net Income P/E P/S EBIT Dividend Directors Dealings Stocks Market capitalization Debt Liabilities Equity AAQS Employees ROE ROA ROCE News Documents

SynCore Biotechnology Co Eulerpool News

SynCore Biotechnology Co Stock News

SynCore Biotechnology Co is being monitored by journalists and investors worldwide. We gather the latest SynCore Biotechnology Co news here.

SynCore Biotechnology Co Stock Press Releases

SynCore Biotechnology Co regularly publishes news on the company's website that are relevant for investors.

SynCore Biotechnology Co News 2026

This page contains all current news, analysis and press releases for SynCore Biotechnology Co stock (4192.TWO, ISIN: TW0004192000). This includes Eulerpool news, company analysis and official press releases. Data is updated regularly to provide investors with a complete overview of the latest developments at SynCore Biotechnology Co.

SynCore Biotechnology Co Stock

SynCore Biotechnology Co SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan.